| 1.0 Introduction
|
(Revised 7/03) |
| 2.0 Section for Communicable
Disease Prevention |
(New 7/03) |
Districts for Statewide Disease Investigation/Terrorism
Response/TB Control |
(Revised 1/08) |
| 3.0 Surveillance Systems |
(Revised 3/05) |
| 4.0 Diseases or Conditions |
|
| Anaplasmosis |
(New 4/08) |
| Animal Bites / Injuries |
(New 7/03) |
| Anthrax |
(Revised 7/03) |
| Blastomycosis
|
(Updated 7/03) |
| Botulism
|
(Revised 7/03) |
| Brucellosis
|
(Revised 11/03) |
| Campylobacteriosis
|
(Updated 7/06) |
| Chancroid
|
(New 7/03) |
| Chlamydia Trachomatis |
(New 7/03) |
| Cholera |
(Revised 11/03) |
| Coccidioidomycosis |
(Updated 7/03) |
| Creutzfeldt-Jakob Disease |
(Updated 7/03) |
| Cryptosporidiosis |
(Revised 9/05) |
| Cyclosporiasis |
(Updated 7/03) |
| Diphtheria |
(New 7/03) |
Escherichia coli O157:H7/Other Hemorrhagic E. coli &
Hemolytic Uremic
Syndrome, (HUS) Post Diarrheal |
(Revised 7/03) |
| Ehrlichiosis
|
(Revised 4/08) |
| Encephalitis, Arboviral |
(Revised 7/03) |
| Eastern
Equine |
|
| Western
Equine |
|
| California
Group |
|
| West
Nile |
|
| St.
Louis |
|
| Giardiasis
|
(Updated 7/03) |
| Glanders |
(New 7/03) |
| Gonorrhea |
(New 7/03) |
| Haemophilus influenzae, Invasive |
(Updated 1/05) |
| Hansen's Disease (Leprosy) |
(Revised 11//03) |
| Hantavirus Pulmonary Syndrome |
(Updated 7/03) |
| Hemorrhagic Fevers (Viral) |
(Updated 4/05) |
|
Arenaviridae: South American Hemorrhagic Viral Fevers (New
World Arenaviruses) |
|
|
Arenaviridae: Lassa Fever (Old World Arenavirus) |
|
|
Bunyaviridae: Crimean-Congo Hemorrhagic Fever |
|
Filoviridae: Ebola Hemorrhagic Fever
|
|
Filoviridae: Marburg Hemorrhagic Fever
|
|
Flaviviridae: Dengue Fever and Dengue Hemorrhagic Fever
|
|
| Hepatitis A |
(Revised 3/08) |
| Hepatitis B, acute/Delta Hepatitis |
(Revised 6/05) |
| Hepatitis C |
(Revised 9/07) |
| HIV/AIDS |
(New 7/03) |
| Influenza |
(Updated 7/03) |
| Latent Tuberculosis Infection |
(New 7/03) |
| Legionellosis |
(Revised 11/03) |
| Leptospirosis |
(Updated 7/03) |
| Listeriosis |
(Updated 7/03) |
| Lyme-like Disease |
(Updated 7/03) |
| Malaria |
(Updated 7/03) |
| Measles |
(New 7/03) |
| Meningococcal Disease |
(Revised 1/08) |
| MOTT |
(New 7/03) |
| Mumps |
(New 7/03) |
| Outbreak Investigation |
(Revised 7/06) |
| Other Sexually Transmitted Diseases |
(New 7/03) |
| Nongonococcal
Urethritis |
|
| Mucopurulent
Cervicitis |
|
| Bacterial
Vaginosis |
|
| Trichomonal
Vaginosis |
|
| Vulvovaginal
Candidiasis |
|
| Genital
Herpes |
|
| Lymphogranuloma
Venereum |
|
| Molluscum
Contagiousum |
|
| Pelvic
Inflammatory Disease (PID) |
|
| Urinary
Tract Infection |
|
| Human
Papillomavirus |
|
| Acute
Epididymitis |
|
| Pertussis |
(New 7/03) |
| Plague |
(Updated 7/03) |
| Polio |
(New 7/03) |
| Psittacosis |
(Updated 3/05) |
| Q Fever |
(Revised 2/08) |
| Rabies |
(Revised 1/05) |
| Ricin |
(New 8/03) |
| Rocky Mountain Spotted Fever |
(Revised 4/08) |
| Rubella |
(New 7/03) |
| Salmonellosis |
(Updated 7/03) |
| Shigellosis |
(Updated 7/03) |
| Smallpox |
(Revised 5/05) |
| Staphylococcal |
(Under Review) |
| Staphylococcal
Enterotoxin B |
|
| Staphylococcal
aureus, Vancomycin Resistant |
|
| Streptococcus Disease
|
|
| Streptococcus Disease, invasive, Group A |
(Revised 6/02) |
| Streptococcus
pneumoniae, drug-resistant invasive disease |
(Revised 12/03) |
| Streptococcus
pneumoniae, invasive disease in children <5 years of age
|
(New 12/03) |
| Streptococcal Toxic Shock Syndrome |
(Revised 6/00) |
| Syphilis |
(New 7/03) |
| T-2 Mycotoxins |
(New 8/03) |
| Tetanus |
(New 7/03) |
| Toxic Shock Syndrome |
(Revised 6/02) |
| Trichinosis |
(Updated 7/03) |
| Tuberculosis Disease |
(New 7/03) |
| Tularemia
|
(Revised 7/03) |
| Typhoid Fever |
(Updated 7/03) |
| Vaccinia,
Adverse Reactions |
(Revised 4/05) |
| Varicella (Chickenpox) |
(Revised 6/05) |
| West
Nile Fever |
(New 7/03) |
| Yellow Fever |
(Updated 7/03) |
| Yersiniosis |
(Updated 7/03) |
| Appendices
|
(Revised 12/01) |
State Home
Disclaimer
